2021 Q1 Form 10-Q Financial Statement

#000156459021029755 Filed on May 25, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $470.8K $284.0K
YoY Change 65.77% -32.38%
Cost Of Revenue $313.4K $80.00K
YoY Change 291.79% -79.54%
Gross Profit $157.4K $13.43K
YoY Change 1072.13% -53.71%
Gross Profit Margin 33.42% 4.73%
Selling, General & Admin $596.2K $1.470M
YoY Change -59.45% 0.0%
% of Gross Profit 378.85% 10949.72%
Research & Development $0.00 $0.00
YoY Change -100.0%
% of Gross Profit 0.0% 0.0%
Depreciation & Amortization $7.996K $0.00
YoY Change -100.0%
% of Gross Profit 5.08% 0.0%
Operating Expenses $596.2K $110.7K
YoY Change 438.6% -92.71%
Operating Profit -$438.8K -$97.26K
YoY Change 351.16% -93.47%
Interest Expense -$922.00 $7.000K
YoY Change -113.17% -73.08%
% of Operating Profit
Other Income/Expense, Net -$1.416K $2.000K
YoY Change -170.8% -95.12%
Pretax Income -$440.2K -$97.26K
YoY Change 352.61% -93.29%
Income Tax $218.3K
% Of Pretax Income
Net Earnings -$658.5K -$97.26K
YoY Change 577.06% -93.29%
Net Earnings / Revenue -139.87% -34.25%
Basic Earnings Per Share
Diluted Earnings Per Share -$14.51K -$0.35
COMMON SHARES
Basic Shares Outstanding 73.23M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.513M $540.0K
YoY Change 1476.56% -93.0%
Cash & Equivalents $8.513M $108.7K
Short-Term Investments $0.00 $50.00K
Other Short-Term Assets $15.03K $1.160M
YoY Change -98.7% -3.17%
Inventory $983.0K $510.0K
Prepaid Expenses $972.2K
Receivables $164.2K $780.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.65M $2.990M
YoY Change 256.11% -68.84%
LONG-TERM ASSETS
Property, Plant & Equipment $446.9K $690.0K
YoY Change -35.23% 375.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $41.86K $380.0K
YoY Change -88.98% -21.81%
Total Long-Term Assets $50.04M $1.060M
YoY Change 4620.35% 67.99%
TOTAL ASSETS
Total Short-Term Assets $10.65M $2.990M
Total Long-Term Assets $50.04M $1.060M
Total Assets $60.68M $4.050M
YoY Change 1398.36% -60.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $142.3K $590.0K
YoY Change -75.87% 64.35%
Accrued Expenses $1.323M $870.0K
YoY Change 52.06% 17.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $404.2K
YoY Change
Total Short-Term Liabilities $1.869M $1.470M
YoY Change 27.17% -59.17%
LONG-TERM LIABILITIES
Long-Term Debt $13.51K $0.00
YoY Change
Other Long-Term Liabilities $162.9K $355.0K
YoY Change -54.11% 76.62%
Total Long-Term Liabilities $176.4K $355.0K
YoY Change -50.3% 76.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.869M $1.470M
Total Long-Term Liabilities $176.4K $355.0K
Total Liabilities $2.046M $1.822M
YoY Change 12.29% -52.07%
SHAREHOLDERS EQUITY
Retained Earnings -$60.45M
YoY Change 8.96%
Common Stock $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.64M $2.229M
YoY Change
Total Liabilities & Shareholders Equity $60.68M $4.051M
YoY Change 1397.99% -60.39%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$658.5K -$97.26K
YoY Change 577.06% -93.29%
Depreciation, Depletion And Amortization $7.996K $0.00
YoY Change -100.0%
Cash From Operating Activities -$2.896M -$215.4K
YoY Change 1244.58% -72.87%
INVESTING ACTIVITIES
Capital Expenditures $12.00K
YoY Change 71.43%
Acquisitions -$3.373M
YoY Change
Other Investing Activities $3.373M $2.720M
YoY Change 24.02% -297.1%
Cash From Investing Activities $3.373M $2.708M
YoY Change 24.57% -295.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.415M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.106M -5.820M
YoY Change -204.91% -821.19%
NET CHANGE
Cash From Operating Activities -2.896M -215.4K
Cash From Investing Activities 3.373M 2.708M
Cash From Financing Activities 6.106M -5.820M
Net Change In Cash 6.583M -215.4K
YoY Change -3156.66% -84.32%
FREE CASH FLOW
Cash From Operating Activities -$2.896M -$215.4K
Capital Expenditures $12.00K
Free Cash Flow -$227.4K
YoY Change -71.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Inventory Net
InventoryNet
983025
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
972155
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
15029
CY2021Q1 us-gaap Gross Profit
GrossProfit
157359
CY2020Q1 us-gaap Gross Profit
GrossProfit
13425
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
585903
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88185
CY2021Q1 adom Consulting Expense
ConsultingExpense
10250
CY2020Q1 adom Consulting Expense
ConsultingExpense
22500
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
596153
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
110685
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-438794
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-97260
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-922
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-494
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1416
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-440210
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-97260
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218300
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-658510
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-97260
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-97260
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45374856
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
53509622
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
156443
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-658510
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-97260
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7996
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
151824
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-38705
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-244488
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
331361
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-416461
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-111115
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1530046
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-98866
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2895880
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-215375
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-3373332
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3373332
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6415110
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
156443
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
152835
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6105832
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6583284
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-215375
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1930132
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
324055
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8513416
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108680
CY2021Q1 us-gaap Stock Issued1
StockIssued1
53509622
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Organization and Operations</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ADOMANI, Inc. (&#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. We serve commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles. Our vehicles address the challenges of traditional fuel price cost instability and local, state and federal regulatory compliance. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 15, 2021, the Company completed its acquisition of Envirotech Drive Systems, Inc., a Delaware corporation (&#8220;EVTDS&#8221;), a supplier of zero-emission trucks, cargo vans, chassis and other commercial vehicles. The transaction was completed in accordance with an Agreement and Plan of Merger, dated February 16, 2021 (the &#8220;Merger Agreement&#8221;), by and among the Company, EVTDS and EVT Acquisition Company, Inc., a Delaware corporation and wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;). <font style="color:#000000;">See Note 3.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates<font style="font-weight:normal;font-style:normal;">&#8212;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></p>
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-right:1.07%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk<font style="font-weight:normal;font-style:normal;">&#8212;</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-right:1.07%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has credit risks related to cash and cash equivalents on deposit with a federally insured bank, as at times it exceeds the $250,000 maximum amount insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). Additionally, the Company maintains cash and short-term securities invested at Morgan Stanley Private Bank, National Association (&#8220;Morgan Stanley&#8221;). Between FDIC and the Securities Investor Protection Corporation (&#8220;SPIC&#8221;) coverage, funds up to $750,000, which may include cash up to $500,000, are insured. In addition, Morgan Stanley provides excess insurance acquired by them from SPIC for an additional $1.9 million in cash and unlimited per customer securities up to a $1 billion cap.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The restricted cash reported by EVTDS as of December 31, 2020, combined with additional cash raised in 2021, was used to fund both the merger closing requirement of $5,000,000 to ADOMANI, Inc. (see Note 3) and to repay liabilities of EVTDS. The amount of restricted cash and corresponding unpaid current liabilities of EVTDS that is included in the consolidated balance sheet at March 31, 2021 is approximately $258,083. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-right:1.07%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended March 31, 2021, total EVTDS sales were to one customer, ADOMANI, Inc., prior to the merger closing (see Note 3). The customer account was collected within two days of invoicing. In addition, the merged entity recorded additional sales during the two weeks post-merger which were made to two other customers and were collected within weeks of invoicing. Accordingly, customer accounts are reported at the invoiced amount outstanding.</p>
CY2021Q1 us-gaap Marketable Securities
MarketableSecurities
0
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Inventory Net
InventoryNet
0
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q1 adom Inventory Deposits
InventoryDeposits
804939
CY2020Q4 adom Inventory Deposits
InventoryDeposits
0
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12992857
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10681327
CY2021Q1 us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
250000
CY2021Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
750000
CY2021Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
500000
CY2021Q1 adom Excess Insurance Acquired From Spic In Cash
ExcessInsuranceAcquiredFromSPICInCash
1900000
CY2021Q1 adom Unlimited Per Customer Securities Cap
UnlimitedPerCustomerSecuritiesCap
1000000000
CY2021Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2021Q1 adom Property Plant And Equipment Threshold For Capitalization Of Purchases
PropertyPlantAndEquipmentThresholdForCapitalizationOfPurchases
2000
CY2021Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
168204000
CY2020Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
290457000
CY2021Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-3302434000
CY2020Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1365240000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
247031
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
252018
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
161595
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24457
CY2021Q1 us-gaap Depreciation
Depreciation
7996
CY2020Q1 us-gaap Depreciation
Depreciation
0
CY2021Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0
CY2020 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
153668
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
255233558
CY2021Q1 adom Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2056326
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.24
CY2021Q1 adom Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualLife
P2Y9M18D
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.29
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M9D
CY2021Q1 us-gaap Number Of Properties Subject To Ground Leases
NumberOfPropertiesSubjectToGroundLeases
6
CY2021Q1 adom Operating Lease Monthly Payment
OperatingLeaseMonthlyPayment
12826
CY2021Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38361
CY2020Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
36387
CY2021Q1 us-gaap Lease Deposit Liability
LeaseDepositLiability
11616
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
46433
CY2021Q1 adom Operating Lease Monthly Payment Due
OperatingLeaseMonthlyPaymentDue
4992
CY2021Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
57846
CY2020Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
31852
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
379151
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
251684
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Two And Three Years
OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears
127466
CY2021Q1 adom Employment Contracts Future Minimum Payments Due
EmploymentContractsFutureMinimumPaymentsDue
112500
CY2021Q1 adom Employment Contracts Future Minimum Payments Due Next Twelve Months
EmploymentContractsFutureMinimumPaymentsDueNextTwelveMonths
112500
CY2021Q1 us-gaap Contractual Obligation
ContractualObligation
491651
CY2021Q1 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
364184
CY2021Q1 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
127466
CY2019Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
13500000.00
CY2019Q2 adom Number Of Shares Refused To Release
NumberOfSharesRefusedToRelease
1320359
CY2020Q1 us-gaap Foreclosed Assets
ForeclosedAssets
582000
CY2021Q1 adom Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
2
CY2021Q1 adom Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
2
CY2021Q1 adom Operating Lease Liability Other Non Current Assets
OperatingLeaseLiabilityOtherNonCurrentAssets
369987
CY2021Q1 adom Operating Lease Liability Other Non Current Assets
OperatingLeaseLiabilityOtherNonCurrentAssets
361453
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
198547
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
adom:CurrentLiabilitiesRelatingToRightOfUseAsset1Member
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
162906
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
adom:NonCurrentLiabilitiesRelatingToRightOfUseAsset1Member
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
11415
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
574884
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
55177
CY2021Q1 us-gaap Lease Cost
LeaseCost
586299
CY2020Q1 us-gaap Lease Cost
LeaseCost
55177
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
28673
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
55177
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y14D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.14

Files In Submission

Name View Source Status
0001564590-21-029755-index-headers.html Edgar Link pending
0001564590-21-029755-index.html Edgar Link pending
0001564590-21-029755.txt Edgar Link pending
0001564590-21-029755-xbrl.zip Edgar Link pending
adom-10q_20210331.htm Edgar Link pending
adom-20210331.xml Edgar Link completed
adom-20210331.xsd Edgar Link pending
adom-20210331_cal.xml Edgar Link unprocessable
adom-20210331_def.xml Edgar Link unprocessable
adom-20210331_lab.xml Edgar Link unprocessable
adom-20210331_pre.xml Edgar Link unprocessable
adom-ex311_9.htm Edgar Link pending
adom-ex312_8.htm Edgar Link pending
adom-ex321_6.htm Edgar Link pending
adom-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending